Strata Critical Medical Inc (SRTA)

Currency in USD
5.590
-0.260(-4.44%)
Closed·
5.500-0.090(-1.61%)
·
SRTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.5705.850
52 wk Range
3.6856.500
Key Statistics
Prev. Close
5.59
Open
5.8
Day's Range
5.57-5.85
52 wk Range
3.685-6.5
Volume
1.19M
Average Volume (3m)
1.2M
1-Year Change
48.2759%
Book Value / Share
3.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SRTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.563
Upside
+71.06%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.563
(+71.06% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Ladenburg Thalmann
Buy11.50+105.72%11.25MaintainMay 07, 2026
Craig-Hallum
Buy8.00+43.11%-New CoverageMar 25, 2026
B.Riley
Buy8.00+43.11%-New CoverageMar 25, 2026
Lake Street Capital Markets
Buy8.00+43.11%-New CoverageDec 02, 2025
Ladenburg Thalmann
Buy11.25+101.25%-New CoverageSep 22, 2025

Strata Critical Medical Inc Earnings Call Summary for Q2/2026

  • Strata Critical Medical Q2 revenue surged 60.7% YoY to $72.5M, beating estimates of $67M, though adjusted loss widened to $0.12/share vs $0.03 expected.
  • Clinical segment drove growth with 22.6% sequential increase to $24.3M; logistics margins fell to 18.4% from 19.3%, missing 20% target amid customer headwinds.
  • Company raised FY2026 guidance: revenue now $285M-$295M (from $260M-$275M); adjusted EBITDA $33M-$35M (from $29M-$33M) on acquisition strength.
  • Management expects Q3 clinical revenue up 20% sequentially, but logistics to decline high-single digits due to customer volume reduction and seasonality.
  • Strata posted $5.7M operating cash flow for second consecutive quarter; completed three acquisitions YTD adding $20M+ revenue at mid-single-digit multiples.
Last Updated: 2026-08-04, 08:44 a/m
Read Full Transcript

Earnings

Latest Release
Aug 04, 2026
EPS / Forecast
-0.12 / -0.03
Revenue / Forecast
72.5M / 66.99M
EPS Revisions
Last 90 days

SRTA Income Statement

Compare SRTA to Peers and Sector

Metrics to compare
SRTA
Peers
Sector
Relationship
P/E Ratio
−21.4x−4.5x−0.4x
PEG Ratio
−0.070.000.00
Price/Book
1.8x2.5x2.6x
Price / LTM Sales
1.9x0.7x3.0x
Upside (Analyst Target)
55.1%27.7%50.7%
Fair Value Upside
Unlock7.8%7.2%Unlock

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
20.64M23.85%120.74M
Other Institutional Investors
48.83M56.43%285.64M
Public Companies & Retail Investors
17.06M19.72%99.80M
Total
86.53M100.00%506.18M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
KSL Advisors, LLC9.16%7,923,00046,350
KSL Capital Partners V, L.P.9.16%7,923,00046,350

People Also Watch

256.65
JAZZ
-1.88%
8.300
ABSI
-1.19%
265.38
NTRA
-3.36%
117.91
FRT
-3.22%
4.870
ARDX
-0.81%

FAQ

What Is the Strata Critical Medical (SRTA) Stock Price Today?

The Strata Critical Medical stock price today is 5.590 USD.

What Stock Exchange Does Strata Critical Medical Trade On?

Strata Critical Medical is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Strata Critical Medical?

The stock symbol for Strata Critical Medical is "SRTA."

What Is the Strata Critical Medical Market Cap?

As of today, Strata Critical Medical market cap is 494.530M USD.

What Is Strata Critical Medical's Earnings Per Share (TTM)?

The Strata Critical Medical EPS (TTM) is 0.475.

When Is the Next Strata Critical Medical Earnings Date?

Strata Critical Medical will release its next earnings report on Nov 11, 2026.

From a Technical Analysis Perspective, Is SRTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Strata Critical Medical Stock Split?

Strata Critical Medical has split 0 times.

How Many Employees Does Strata Critical Medical Have?

Strata Critical Medical has 327 employees.

What is the current trading status of Strata Critical Medical (SRTA)?

As of Aug 07, 2026, Strata Critical Medical (SRTA) is trading at a price of 5.590 USD, with a previous close of 5.590 USD. The stock has fluctuated within a day range of 5.570 USD to 5.850 USD, while its 52-week range spans from 3.685 USD to 6.500 USD.

What Is Strata Critical Medical (SRTA) Price Target According to Analysts?

The average 12-month price target for Strata Critical Medical is 9.563 USD, with a high estimate of 12.75 USD and a low estimate of 8 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +71.06% Upside potential.

What Is the SRTA Premarket Price?

SRTA's last pre-market stock price is 5.500 USD. The pre-market share volume is 160.000, and the stock has decreased by -0.090, or -1.610%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.